Gambaran Umum
Medicus Pharma Ltd. is a pharmaceutical company based in the United Kingdom, primarily engaged in the development and manufacturing of generic and proprietary pharmaceuticals. A significant portion of its operations is directed towards the research and development of innovative drug delivery systems, aimed at enhancing the efficacy and safety of existing medicinal compounds. Key projects have included the development of extended-release formulations for cardiovascular drugs, as well as partnerships aimed at tackling prevalent chronic conditions such as diabetes and arthritis. Medicus Pharma has garnered attention for its commitment to high manufacturing standards and its strategic collaborations with both global and regional distributors to expand its market reach, thereby strengthening its position in the competitive pharmaceutical industry.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Medicus Pharma Ltd. per 2025 Jun 30 adalah -17.06 MM.
- Nilai net income untuk Medicus Pharma Ltd. per 2025 Jun 30 adalah -17.09 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | -17.06 | -17.09 | |
| 2025-03-31 | -14.60 | -14.55 | |
| 2024-12-31 | -11.18 | -11.16 | |
| 2024-09-30 | -11.84 | -9.68 | |
| 2024-06-30 | -9.06 | -9.68 | |
| 2024-03-31 | -5.76 | -6.54 | |
| 2023-12-31 | -4.46 | -5.31 | |
| 2023-09-30 | -1.07 | -4.26 | |
| 2023-06-30 | -1.11 | -1.68 | |
| 2023-03-31 | -1.11 | -1.74 | |
| 2022-12-31 | -0.98 | -1.69 | |
| 2021-12-31 | -1.44 | -2.06 |
Laporan Laba Rugi: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | ||
| 2022-12-31 | ||
| 2021-12-31 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Medicus Pharma Ltd. per 2025 Jun 30 adalah -15.70 MM.
- Nilai kas dari aktivitas pendanaan untuk Medicus Pharma Ltd. per 2025 Jun 30 adalah 16.96 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | -15.70 | 16.96 | |
| 2025-03-31 | -13.01 | 16.45 | |
| 2024-12-31 | -10.25 | 12.69 | |
| 2024-09-30 | -10.41 | 10.61 | |
| 2024-06-30 | -7.49 | 15.75 | |
| 2024-03-31 | -5.10 | 5.61 | |
| 2023-12-31 | -4.16 | 5.61 | |
| 2023-09-30 | -1.10 | 6.20 | |
| 2023-06-30 | -1.13 | 1.14 | |
| 2023-03-31 | -1.02 | 0.64 | |
| 2022-12-31 | -1.06 | 1.25 | |
| 2021-12-31 | -1.45 | 0.88 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2021-12-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | ||
| 2022-12-31 | ||
| 2021-12-31 |
Efektivitas Manajemen
- roa untuk Medicus Pharma Ltd. pada 2025 Jun 30 adalah -1.95.
- roe untuk Medicus Pharma Ltd. pada 2025 Jun 30 adalah -2.65.
- roic untuk Medicus Pharma Ltd. pada 2025 Jun 30 adalah -2.05.
- croic untuk Medicus Pharma Ltd. pada 2025 Jun 30 adalah 0.15.
- ocroic untuk Medicus Pharma Ltd. pada 2025 Jun 30 adalah -1.88.
| Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
| 2025-06-30 | -1.95 | -2.65 | -2.05 | 0.15 | -1.88 |
| 2025-03-31 | -14.77 | -5.68 | 1.34 | -5.08 | |
| 2024-12-31 | -5.89 | -13.84 | -3.10 | 0.68 | -2.85 |
| 2024-09-30 | -2.24 | -3.26 | -2.97 | 0.05 | -2.70 |
| 2024-06-30 | -217.06 | ||||
| 2024-03-31 | -24.00 | -40.88 | 8.75 | -25.06 | |
| 2023-12-31 | -0.73 | 0.87 | -0.19 | ||
| 2023-09-30 | |||||
| 2023-06-30 | -21.43 | ||||
| 2023-03-31 | -22.14 | ||||
| 2022-12-31 | |||||
| 2021-12-31 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
| Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2021-12-31 |
Pengenal dan Deskriptor
| Kunci Indeks Pusat (CIK) |
